Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.87B | 3.87B | 3.63B | 3.74B | 3.36B | 2.60B |
Gross Profit | 2.78B | 2.78B | 2.61B | 2.59B | 2.46B | 1.87B |
EBITDA | 927.00M | 927.00M | 917.90M | 974.50M | 893.10M | 818.60M |
Net Income | 540.50M | 540.50M | 601.00M | 647.50M | 649.00M | 581.00M |
Balance Sheet | ||||||
Total Assets | 5.92B | 5.92B | 5.79B | 5.55B | 5.59B | 5.93B |
Cash, Cash Equivalents and Short-Term Investments | 687.10M | 687.10M | 513.80M | 414.80M | 612.00M | 1.77B |
Total Debt | 1.76B | 1.76B | 1.79B | 1.81B | 1.48B | 1.83B |
Total Liabilities | 3.24B | 3.24B | 3.30B | 3.32B | 3.16B | 3.15B |
Stockholders Equity | 2.66B | 2.66B | 2.47B | 2.21B | 2.41B | 2.75B |
Cash Flow | ||||||
Free Cash Flow | 656.10M | 656.10M | 624.70M | 609.10M | 815.90M | 665.50M |
Operating Cash Flow | 793.70M | 793.70M | 753.30M | 763.40M | 922.50M | 754.70M |
Investing Cash Flow | -212.70M | -212.70M | -234.00M | -429.50M | -707.00M | -123.60M |
Financing Cash Flow | -401.80M | -401.80M | -415.30M | -523.50M | -1.37B | 687.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | CHF13.28B | 25.54 | ― | 1.99% | 6.58% | -10.02% | |
73 Outperform | 3.03B | 34.16 | 19.20% | 0.46% | 16.59% | 65.76% | |
71 Outperform | 14.35B | 36.83 | 19.03% | 1.06% | 4.49% | 45.08% | |
67 Neutral | 1.98B | 31.61 | 4.71% | 1.94% | -9.34% | -37.50% | |
61 Neutral | 1.21B | -2,262.76 | 1.31% | ― | 7.29% | -112.70% | |
56 Neutral | 4.81B | 54.59 | 12.87% | 0.62% | 36.54% | 11.60% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
Sonova has launched the Phonak Virto R Infinio, its first rechargeable in-ear hearing aid, marking the company’s entry into this growing market segment. This product, available initially in the USA, combines advanced technology for better speech understanding and connectivity, and represents a significant step in expanding Sonova’s product portfolio to meet diverse customer needs.
The most recent analyst rating on (CH:SOON) stock is a Sell with a CHF224.00 price target. To see the full list of analyst forecasts on Sonova Holding AG stock, see the CH:SOON Stock Forecast page.